| FPACX | FPCSX | FPACX / FPCSX | |
| Total Expense Ratio | 1.06 | 1.00 | 106% |
| Annual Report Gross Expense Ratio | 1.08 | 1.02 | 106% |
| Fund Existence | 33 years | 5 years | - |
| Gain YTD | 14.574 | 14.621 | 100% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1500 | 100000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 12B | 12B | 100% |
| Annual Yield % from dividends | 1.87 | 1.86 | 100% |
| Returns for 1 year | 8.04 | 8.13 | 99% |
| Returns for 3 years | 38.62 | 38.91 | 99% |
| Returns for 5 years | 33.69 | 34.09 | 99% |
| Returns for 10 years | 46.16 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SNTH | 31.17 | 0.13 | +0.42% |
| MRP Synthequity ETF | |||
| MYCM | 25.02 | 0.02 | +0.06% |
| SPDR SSGA My2033 Corporate Bond ETF | |||
| PBE | 81.50 | -0.01 | -0.01% |
| Invesco Biotechnology & Genome ETF | |||
| IBIF | 26.31 | N/A | -0.01% |
| iShares iBonds Oct 2029 Term Tips ETF | |||
| RWO | 45.76 | -0.05 | -0.11% |
| SPDR® Dow Jones® Global Real Estate ETF | |||